Related Experiment Video
Updated: Dec 8, 2025

Corneal Epithelial Abrasion with Ocular Burr As a Model for Cornea Wound Healing
Published on: July 10, 2018
Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity
Steffi Daniel1, Marian Renwick1, Viet Q Chau1
1Department of Ophthalmology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, USA.
Abstract:
Fibulin-3 (F3) is an extracellular matrix glycoprotein found in basement membranes across the body. An autosomal dominant R345W mutation in F3 causes a macular dystrophy resembling dry age-related macular degeneration (AMD), whereas genetic removal of wild-type (WT) F3 protects mice from sub-retinal pigment epithelium (RPE) deposit formation. These observations suggest that F3 is a protein which can regulate pathogenic sub-RPE deposit formation in the eye. Yet the precise role of WT F3 within the eye is still largely unknown. We found that F3 is expressed throughout the mouse eye (cornea, trabecular meshwork (TM) ring, neural retina, RPE/choroid, and optic nerve). We next performed a thorough structural and functional characterization of each of these tissues in WT and homozygous (F3-/-) knockout mice. The corneal stroma in F3-/- mice progressively thins beginning at 2 months, and the development of corneal opacity and vascularization starts at 9 months, which worsens with age. However, in all other tissues (TM, neural retina, RPE, and optic nerve), gross structural anatomy and functionality were similar across WT and F3-/- mice when evaluated using SD-OCT, histological analyses, electron microscopy, scotopic electroretinogram, optokinetic response, and axonal anterograde transport. The lack of noticeable retinal abnormalities in F3-/- mice was confirmed in a human patient with biallelic loss-of-function mutations in F3. These data suggest that (i) F3 is important for maintaining the structural integrity of the cornea, (ii) absence of F3 does not affect the structure or function of any other ocular tissue in which it is expressed, and (iii) targeted silencing of F3 in the retina and/or RPE will likely be well-tolerated, serving as a safe therapeutic strategy for reducing sub-RPE deposit formation in disease. KEY MESSAGES: • Fibulins are expressed throughout the body at varying levels. • Fibulin-3 has a tissue-specific pattern of expression within the eye. • Lack of fibulin-3 leads to structural deformities in the cornea. • The retina and RPE remain structurally and functionally healthy in the absence of fibulin-3 in both mice and humans.
Insights
Fibulin-3 (F3) is crucial for corneal integrity but not essential for retinal or RPE function. Its absence in mice and humans shows potential for safe therapeutic strategies targeting eye diseases like AMD.
Area of Science:
- Ophthalmology
- Extracellular Matrix Biology
- Genetics
Background:
- Fibulin-3 (F3) is an extracellular matrix glycoprotein implicated in eye diseases.
- A mutation in F3 causes macular dystrophy, and its absence protects mice from sub-retinal pigment epithelium (RPE) deposits.
- The precise role of wild-type (WT) F3 in ocular tissues remains largely unknown.
Purpose of the Study:
- To investigate the tissue-specific expression and function of Fibulin-3 (F3) within the eye.
- To characterize the structural and functional consequences of F3 absence in ocular tissues.
- To evaluate the potential of F3 as a therapeutic target for retinal diseases.
Main Methods:
- Analysis of F3 expression across various mouse ocular tissues.
- Structural and functional evaluation of ocular tissues in WT and F3 knockout (F3-/-) mice.
- Utilized SD-OCT, histology, electron microscopy, electroretinogram, and optokinetic response tests.
Main Results:
- F3 knockout mice exhibit progressive corneal thinning, opacity, and vascularization with age.
- No significant structural or functional abnormalities were observed in the trabecular meshwork, neural retina, RPE, or optic nerve of F3-/- mice.
- Absence of F3 in a human patient with loss-of-function mutations showed no retinal abnormalities.
Conclusions:
- Fibulin-3 is essential for maintaining corneal structural integrity.
- The absence of F3 does not compromise the structure or function of other ocular tissues, including the retina and RPE.
- Targeted F3 inhibition presents a potentially safe therapeutic strategy for reducing sub-RPE deposits in diseases like age-related macular degeneration (AMD).

